BMY
Price
$62.58Alerts
Change
-$0.33 (-0.52%)
Updated
Nov 12, 03:12 PM (EDT)
Capitalization
126.93B
84 days until earnings call
Intraday BUY SELL Signals
RXL
Price
$73.05Alerts
Change
+$0.10 (+0.14%)
Updated
Nov 12, 02:18 PM (EDT)
Net Assets
113.09M
Intraday BUY SELL Signals
Interact to see
Advertisement

BMY vs RXL

BMY vs RXL Comparison Chart in %
View a ticker or compare two or three
VS
BMY vs. RXL commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMY is a Buy and RXL is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for BMY with price predictions
Nov 11, 2026

Aroon Indicator for BMY shows an upward move is likely

BMY's Aroon Indicator triggered a bullish signal on November 11, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 217 similar instances where the Aroon Indicator showed a similar pattern. In 147 of the 217 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 68%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BMY's RSI Indicator exited the oversold zone, 11 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 37%.

The Momentum Indicator moved above the 0 level on October 19, 2026. You may want to consider a long position or call options on BMY as a result. In 51 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 56%.

The Moving Average Convergence Divergence (MACD) for BMY just turned positive on October 16, 2026. Looking at past instances where BMY's MACD turned positive, the stock continued to rise in 29 of 50 cases over the following month. The odds of a continued upward trend are 58%.

BMY moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for BMY crossed bullishly above the 50-day moving average on November 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 60%.

Following a +1.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMY advanced for three days, in 175 of 309 cases, the price rose further within the following month. The odds of a continued upward trend are 57%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 40 of 68 cases where BMY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 59%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.

BMY broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 22 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating fairly steady price growth. BMY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 63 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 67 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 59, placing this stock worse than average.

The Tickeron Valuation Rating of 96 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.687) is normal, around the industry mean (-1.421). P/E Ratio (13.627) is within average values for comparable stocks, (21.700). BMY's Projected Growth (PEG Ratio) (17.786) is slightly higher than the industry average of (5.738). Dividend Yield (0.041) settles around the average of (0.038) among similar stocks. P/S Ratio (2.642) is also within normal values, averaging (4.033).

A.I.Advisor
a Summary for RXL with price predictions
Nov 11, 2026

RXL's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for RXL turned positive on October 09, 2026. Looking at past instances where RXL's MACD turned positive, the stock continued to rise in 41 of 46 cases over the following month. The odds of a continued upward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on RXL as a result. In 78 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 86%.

RXL moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for RXL crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 87%.

Following a +0.59% 3-day Advance, the price is estimated to grow further. Considering data from situations where RXL advanced for three days, in 276 of 322 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.

The Aroon Indicator entered an Uptrend today. In 227 of 255 cases where RXL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 89%.

Bearish Trend Analysis

The 10-day RSI Indicator for RXL moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In 22 of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at 76%.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RXL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

RXL broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

FUNDAMENTALS RATINGS
BMY: Fundamental Ratings
BMY
OUTLOOK RATING
1..100
32
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
67
SMR RATING
1..100
22
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
63
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BMYRXL
RSI
ODDS (%)
Bullish Trend 2 days ago
37%
Bearish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
86%
Declines
ODDS (%)
Bearish Trend 7 days ago
55%
Bearish Trend 7 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
89%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (BMY: $62.91)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMY’s FA Score shows that 1 FA rating(s) are green while .

  • BMY’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMY’s TA Score shows that 7 TA indicator(s) are bullish.

  • BMY’s TA Score: 7 bullish, 3 bearish.

Price Growth

BMY (@Pharmaceuticals: Major) experienced а -1.99% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.97%. For the same industry, the average monthly price growth was +4.05%, and the average quarterly price growth was +6.70%.

Reported Earning Dates

BMY is expected to report earnings on Feb 04, 2027.

Industries' Descriptions

@Pharmaceuticals: Major (+0.97% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

View a ticker or compare two or three
Interact to see
Advertisement

BMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMY has been loosely correlated with PFE. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if BMY jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMY
1D Price
Change %
BMY100%
+0.18%
PFE - BMY
61%
Loosely correlated
+0.31%
GSK - BMY
52%
Loosely correlated
-1.23%
ABBV - BMY
50%
Loosely correlated
+0.37%
NVS - BMY
49%
Loosely correlated
-1.80%
MRK - BMY
49%
Loosely correlated
-0.59%
More

RXL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXL has been closely correlated with LLY. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXL jumps, then LLY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXL
1D Price
Change %
RXL100%
+0.10%
LLY - RXL
75%
Closely correlated
+0.35%
MRK - RXL
67%
Closely correlated
-0.59%
ABBV - RXL
66%
Loosely correlated
+0.37%
JNJ - RXL
65%
Loosely correlated
-0.13%
BMY - RXL
62%
Loosely correlated
+0.18%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WHWK3.240.16
+5.19%
Whitehawk Therapeutics Inc
CODI12.200.27
+2.26%
Compass Diversified
FISV63.900.58
+0.92%
Fiserv Inc.
BOLT6.26-0.04
-0.63%
Bolt Biotherapeutics Inc
RLAY19.72-0.22
-1.10%
Relay Therapeutics